Vial

Technology-driven clinical trial management services

San Francisco, California, United States

About Vial

Vial operates in the clinical trials market as a technology-driven Contract Research Organization (CRO). The company helps pharmaceutical and biotechnology clients conduct clinical trials more efficiently and at a larger scale. Its main product is the Vial Technology Platform, which replaces traditional paper-based methods with connected systems and an intuitive design, allowing for smoother transitions between different trial visits and phases. Vial differentiates itself from competitors by offering a fixed-fee pricing model, providing clients with cost certainty and maximizing their return on investment. The company's goal is to empower scientists to cure all human diseases by delivering faster and more efficient trials, while also contributing to industry knowledge through thought leadership initiatives.

San Francisco, CaliforniaHeadquarters
2020Year Founded
$65.2MTotal Funding
SERIES_BCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Unlimited PTO
Health, dental & vision
Paid parental leave
Remote-first culture
Competitive Equity Compensation

Risks

Emerging competition from companies like Avicenna could challenge Vial's market position.
Failure to integrate HEOR could affect the marketability of therapies developed by Vial.
Rapid advancements in gene-editing technologies may require Vial to adapt its methodologies.

Differentiation

Vial uses a proprietary technology platform to streamline clinical trial processes.
The company offers a fixed-fee pricing model, providing cost certainty for clients.
Vial publishes industry-leading white papers, establishing thought leadership in clinical trials.

Upsides

Vial's partnership with Mason enhances remote management of clinical trial devices.
The 'First in Human' podcast boosts Vial's brand visibility and industry influence.
Vial's fixed-fee model maximizes ROI for clients, encouraging efficient trial completion.